ENOVIS CORP (ENOV) — insider trading
Health Care · NYSE
ENOVIS CORP (ENOV) has 13 reported SEC Form 4 insider transactions in our data, including 5 open-market purchases among the most recent 13 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Ortiz Christine | Director | Grant / award / vesting | 846 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Engert Oliver | Officer (Chief Administrative Officer) | Open-market purchase | 1,000 | $20.92 | $20.9K | Form 4 |
| 2026-06-11 | Engert Oliver | Officer (Chief Administrative Officer) | Grant / award / vesting | 1,000 | $20.99 | $21.0K | Form 4/A |
| 2026-06-11 | Engert Oliver | Officer (Chief Administrative Officer) | Open-market purchase | 1,000 | $21.75 | $21.8K | Form 4 |
| 2026-06-11 | Engert Oliver | Officer (Chief Administrative Officer) | Open-market purchase | 200 | $20.99 | $4.2K | Form 4 |
| 2026-06-10 | Engert Oliver | Officer (Chief Administrative Officer) | Open-market purchase | 1,000 | $23.00 | $23.0K | Form 4 |
| 2026-06-01 | Engert Oliver | Officer (Chief Administrative Officer) | Open-market purchase | 1,000 | $22.22 | $22.2K | Form 4 |
| 2026-05-19 | PERFALL A CLAYTON | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Lalor Angela S | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Ortiz Christine | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Okala Philip | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Bodem Barbara W. | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Shirley Brady | Director | Grant / award / vesting | 9,346 | $0.00 | $0 | Form 4 |
Ask the chat about ENOV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ENOVIS CORP (ENOV).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.